Review



biotinylated vvl 536  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Vector Laboratories biotinylated vvl 536
    Biotinylated Vvl 536, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 167 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm42024456-237-3-8
    Average 95 stars, based on 167 article reviews
    biotinylated vvl 536 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.
    Article Snippet: INTRODUCTION: Macrophages in the tumor microenvironment exert antitumorigenic effects through phagocytosis and/or direct tumoricidal activity.. Phagocytosis of tumor cells occurs through both antibodydependent cellular phagocytosis (ADCP) and antibodyindependent cellular phagocytosis (AICP) mechanisms.. Despite the strong evidence that macrophages can mediate tumor control in acute myeloid leukemia (AML) and other diseases, therapeutic agents that enhance macrophage phagocytosis, including antiCD47 neutralizing antibodies, have not led to improved clinical outcomes.

    Staining:

    Article Title: Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.
    Article Snippet: INTRODUCTION: Macrophages in the tumor microenvironment exert antitumorigenic effects through phagocytosis and/or direct tumoricidal activity.. Phagocytosis of tumor cells occurs through both antibodydependent cellular phagocytosis (ADCP) and antibodyindependent cellular phagocytosis (AICP) mechanisms.. Despite the strong evidence that macrophages can mediate tumor control in acute myeloid leukemia (AML) and other diseases, therapeutic agents that enhance macrophage phagocytosis, including antiCD47 neutralizing antibodies, have not led to improved clinical outcomes.

    Article Title: GALNT1 drives aggressive phenotypes of rheumatoid synoviocytes via NEK9 O‑glycosylation.
    Article Snippet: For the staining of GALNT1 or NEK9, 560 anti-GALNT1 (1:50, HPA012628, Sigma-Aldrich, USA, polyclonal antibody) or anti-561 NEK9 (1:50, sc-100401, Santa Cruz, USA, clone: 39-7) was utilized. .. For VVL 562 staining, biotinylated VVL (1:100, B-1235-2, Vector Labs, USA) and HRP-563 Streptavidin (1:200, SE068, Solarbio, China) were used. ..

    Incubation:

    Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer
    Article Snippet: HRP-conjugated goat anti-rabbit IgG (1:5000, SA00001-2, Proteintech) was applied for 1 h at room temperature. .. To detect O-glycosylated proteins, membranes were incubated overnight with biotinylated Vicia villosa agglutinin (VVA; 1:1000, B-1235, Vector), a lectin that specifically recognizes the Tn antigen (GalNAc-O-Ser/Thr), the initial product of mucin-type O-glycosylation. ..

    Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer.
    Article Snippet: HRP-conjugated goat anti-rabbit IgG (1:5000, SA00001-2, Proteintech) was applied for 1 h at room temperature. .. To detect O-glycosylated proteins, membranes were incubated overnight with biotinylated Vicia villosa agglutinin (VVA; 1:1000, B-1235, Vector), a lectin that specifically recognizes the Tn antigen (GalNAc-O-Ser/Thr), the initial product of mucin-type O-glycosylation. ..

    Article Title: Abnormal glycosylation of MUC20 mediates TAM polarization and promotes immune escape in colorectal cancer.
    Article Snippet: .. 4 μg of Bio-VVA (B-1235-2, Vector Laboratories) was incubated with 600 μg of protein at 4°C for 3 hours. ..

    Article Title: GALNT1 emerges as a potential therapeutic target in breast cancer
    Article Snippet: .. Samples were incubated overnight at 4 °C with anti-GALNT1 (1:200, 21139-1-AP, Proteintech), anti-PDI (1:200, #222581, Zenbio), anti-FAP (1:200, #222271, Zenbio), or biotinylated Vicia villosa agglutinin (VVA, 1:100, B-1235, Vector). .. After incubated with fluorescent secondary antibodies (1:500, Proteintech) and DAPI nuclear staining (Solarbio), fluorescence images were captured on both inverted and upright microscopes.



    Similar Products

    95
    Vector Laboratories biotinylated vvl 536
    Biotinylated Vvl 536, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm42024456-237-3-8
    Average 95 stars, based on 1 article reviews
    biotinylated vvl 536 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories biotinylated vvl
    Biotinylated Vvl, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm42024456-251-4-8
    Average 95 stars, based on 1 article reviews
    biotinylated vvl - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories bio vva
    Bio Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm41965932-133-3-5
    Average 95 stars, based on 1 article reviews
    bio vva - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories pna biotin
    Pna Biotin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm41955354-386-42-45
    Average 95 stars, based on 1 article reviews
    pna biotin - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories biotinylated vicia villosa agglutinin
    Biotinylated Vicia Villosa Agglutinin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pmc13018511-56-9-16
    Average 95 stars, based on 1 article reviews
    biotinylated vicia villosa agglutinin - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories biotinylated vva
    Biotinylated Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/bio_rxiv__64898__2026__03__02__708854-231-21-22
    Average 95 stars, based on 1 article reviews
    biotinylated vva - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories vva
    A) SLC35A2 encodes a transporter for UDP-galactose, which is required for the synthesis of O-GalNAc glycans. B) The lectin <t>VVA</t> binds terminal alpha-GalNAc (Tn-antigen), while PNA binds terminal Gal of Core 1 O-GalNAc glycans (T-antigen), which can be removed by O-glycosidase (OGA). C) Breeding strategy of Emx1-Cre mice with floxed- Slc35a2 mice, with blue regions highlighting the forebrain expression Emx1 . D) VVA binding is minimal in protein blots of wild-type mouse cortex; female (+/+) and male (+/y) with floxed- Slc35a2 . In contrast, mice lacking Slc35a2 in cells expressing the forebrain-specific promoter Emx1 ( Emx1-Cre ) display robust VVA binding in both females (+/-) and males (-/y), consistent with inhibition of O-GalNAc extension. Binding of PNA after Neuraminidase A (NeuA) treatment was significantly reduced in both +/- and -/y lines, and specificity of PNA binding was confirmed via OGA treatment of a +/+ <t>sample.</t> <t>ConA,</t> which binds all N-glycans, was unaffected in all mouse lines, and specificity was confirmed using peptide N-glycosidase F (PNGase F) treatment of a +/+ sample. Each lane contains 15 µg cortical protein lysate from an individual mouse of the corresponding genotype. Experiment was replicated three times with similar results. E) Quantification of lectin binding from D normalized to total protein (TP) staining within the same lane of each blot. Data presented as the mean binding intensity +/- SEM, with data points for each individual mouse included, N = 3/genotype. One-way ANOVA confirmed significant group differences ( p < 0.05) for VVA and PNA but not ConA, followed by post hoc Student’s t-tests to confirm genotype effects in each sex: ** p -value = 0.01, **** p -value = 0.0001. F) Schematic of coronal mouse brain section highlighting the cortex (CTX), corpus callosum (CC), and basal ganglia (BG). G) VVA binding is minimal across all regions in wildtype mouse cortex (+/y), while PNA binding localizes to neuronal tracts of the CC and axon bundles in the BG. In contrast, mice lacking forebrain expression of Slc35a2 (-/y) display a build-up of truncated O-GalNAc glycans in cortex that fail to properly localize. Mature O-GalNAc glycans are entirely absent from the CTX and CC, but preserved in the BG, which does not express Emx1 -Cre. H) Relative quantification of lectin binding across brain regions (CTX, CC, BG) from G. Data presented as the mean binding intensity +/- SEM, with individual points representing the average of 6 measures across independent mice. Colored bars correspond with the specific brain region indicated in (F): CTX, purple; CC, orange; BG, blue. N = 2 for +/y VVA; N = 4 for +/- PNA, -/y VVA, and -/y PNA. Fluorescence was quantified as arbitrary intensity (a.i.) after subtracting background signal from each sample.
    Vva, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/B-1235-2/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/bio_rxiv__64898__2026__03__02__708854-295-7-8
    Average 95 stars, based on 1 article reviews
    vva - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    A) SLC35A2 encodes a transporter for UDP-galactose, which is required for the synthesis of O-GalNAc glycans. B) The lectin VVA binds terminal alpha-GalNAc (Tn-antigen), while PNA binds terminal Gal of Core 1 O-GalNAc glycans (T-antigen), which can be removed by O-glycosidase (OGA). C) Breeding strategy of Emx1-Cre mice with floxed- Slc35a2 mice, with blue regions highlighting the forebrain expression Emx1 . D) VVA binding is minimal in protein blots of wild-type mouse cortex; female (+/+) and male (+/y) with floxed- Slc35a2 . In contrast, mice lacking Slc35a2 in cells expressing the forebrain-specific promoter Emx1 ( Emx1-Cre ) display robust VVA binding in both females (+/-) and males (-/y), consistent with inhibition of O-GalNAc extension. Binding of PNA after Neuraminidase A (NeuA) treatment was significantly reduced in both +/- and -/y lines, and specificity of PNA binding was confirmed via OGA treatment of a +/+ sample. ConA, which binds all N-glycans, was unaffected in all mouse lines, and specificity was confirmed using peptide N-glycosidase F (PNGase F) treatment of a +/+ sample. Each lane contains 15 µg cortical protein lysate from an individual mouse of the corresponding genotype. Experiment was replicated three times with similar results. E) Quantification of lectin binding from D normalized to total protein (TP) staining within the same lane of each blot. Data presented as the mean binding intensity +/- SEM, with data points for each individual mouse included, N = 3/genotype. One-way ANOVA confirmed significant group differences ( p < 0.05) for VVA and PNA but not ConA, followed by post hoc Student’s t-tests to confirm genotype effects in each sex: ** p -value = 0.01, **** p -value = 0.0001. F) Schematic of coronal mouse brain section highlighting the cortex (CTX), corpus callosum (CC), and basal ganglia (BG). G) VVA binding is minimal across all regions in wildtype mouse cortex (+/y), while PNA binding localizes to neuronal tracts of the CC and axon bundles in the BG. In contrast, mice lacking forebrain expression of Slc35a2 (-/y) display a build-up of truncated O-GalNAc glycans in cortex that fail to properly localize. Mature O-GalNAc glycans are entirely absent from the CTX and CC, but preserved in the BG, which does not express Emx1 -Cre. H) Relative quantification of lectin binding across brain regions (CTX, CC, BG) from G. Data presented as the mean binding intensity +/- SEM, with individual points representing the average of 6 measures across independent mice. Colored bars correspond with the specific brain region indicated in (F): CTX, purple; CC, orange; BG, blue. N = 2 for +/y VVA; N = 4 for +/- PNA, -/y VVA, and -/y PNA. Fluorescence was quantified as arbitrary intensity (a.i.) after subtracting background signal from each sample.

    Journal: bioRxiv

    Article Title: Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2 -associated epilepsy

    doi: 10.64898/2026.03.02.708854

    Figure Lengend Snippet: A) SLC35A2 encodes a transporter for UDP-galactose, which is required for the synthesis of O-GalNAc glycans. B) The lectin VVA binds terminal alpha-GalNAc (Tn-antigen), while PNA binds terminal Gal of Core 1 O-GalNAc glycans (T-antigen), which can be removed by O-glycosidase (OGA). C) Breeding strategy of Emx1-Cre mice with floxed- Slc35a2 mice, with blue regions highlighting the forebrain expression Emx1 . D) VVA binding is minimal in protein blots of wild-type mouse cortex; female (+/+) and male (+/y) with floxed- Slc35a2 . In contrast, mice lacking Slc35a2 in cells expressing the forebrain-specific promoter Emx1 ( Emx1-Cre ) display robust VVA binding in both females (+/-) and males (-/y), consistent with inhibition of O-GalNAc extension. Binding of PNA after Neuraminidase A (NeuA) treatment was significantly reduced in both +/- and -/y lines, and specificity of PNA binding was confirmed via OGA treatment of a +/+ sample. ConA, which binds all N-glycans, was unaffected in all mouse lines, and specificity was confirmed using peptide N-glycosidase F (PNGase F) treatment of a +/+ sample. Each lane contains 15 µg cortical protein lysate from an individual mouse of the corresponding genotype. Experiment was replicated three times with similar results. E) Quantification of lectin binding from D normalized to total protein (TP) staining within the same lane of each blot. Data presented as the mean binding intensity +/- SEM, with data points for each individual mouse included, N = 3/genotype. One-way ANOVA confirmed significant group differences ( p < 0.05) for VVA and PNA but not ConA, followed by post hoc Student’s t-tests to confirm genotype effects in each sex: ** p -value = 0.01, **** p -value = 0.0001. F) Schematic of coronal mouse brain section highlighting the cortex (CTX), corpus callosum (CC), and basal ganglia (BG). G) VVA binding is minimal across all regions in wildtype mouse cortex (+/y), while PNA binding localizes to neuronal tracts of the CC and axon bundles in the BG. In contrast, mice lacking forebrain expression of Slc35a2 (-/y) display a build-up of truncated O-GalNAc glycans in cortex that fail to properly localize. Mature O-GalNAc glycans are entirely absent from the CTX and CC, but preserved in the BG, which does not express Emx1 -Cre. H) Relative quantification of lectin binding across brain regions (CTX, CC, BG) from G. Data presented as the mean binding intensity +/- SEM, with individual points representing the average of 6 measures across independent mice. Colored bars correspond with the specific brain region indicated in (F): CTX, purple; CC, orange; BG, blue. N = 2 for +/y VVA; N = 4 for +/- PNA, -/y VVA, and -/y PNA. Fluorescence was quantified as arbitrary intensity (a.i.) after subtracting background signal from each sample.

    Article Snippet: Biotinylated lectins ConA (VectorLabs,#B-1005-5, 25 μg/mL) and VVA (VectorLabs, #B-1235-2, 25 μg/mL) were diluted in TBS-T and incubated for 1 hour at room temperature.

    Techniques: Expressing, Binding Assay, Inhibition, Staining, Quantitative Proteomics, Fluorescence